• FirefoxUpgrade to the new Firefox »
  •  Dow Up 0.15% Nasdaq Down 0.04%

    Amgen Inc. (AMGN)

    -NasdaqGS
    169.29 Up 0.81(0.48%) 9:31AM EST - Nasdaq Real Time Price
    Add to Portfolio
    Prev Close:168.48
    Open:N/A
    Bid:168.42 x 700
    Ask:168.69 x 100
    1y Target Est:168.81
    Beta:0.43
    Earnings Date:Jan 26 - Jan 30 (Est.)
    Day's Range:168.07 - 169.90
    52wk Range:108.20 - 173.14
    Volume:106,176
    Avg Vol (3m):4,067,150
    Market Cap:128.77B
    P/E (ttm):26.65
    EPS (ttm):6.35
    Div & Yield:2.44 (1.50%)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for AMGN

    Comparison

    Symbol% ChgMkt Cap
    AMGNUp 0.48%128.77B
    JNJUp 0.10%299.28B
    NVSDown 0.20%228.28B
    TEVAUp 0.44%48.64B

    Key Statistics

    Forward P/E (1 yr):18.06
    P/S (ttm):6.49
    Ex-Dividend Date:10-Nov-14

    Analysts

    Annual EPS Est (Dec-14) :8.61
    Quarterly EPS Est (Dec-14) :2.05
    Mean Recommendation*:2.3
    PEG Ratio (5 yr expected):1.76

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Amgen Inc., a biotechnology company, discovers, develops, manufactures, and delivers human therapeutics in the areas of oncology, hematology, inflammation, bone health, nephrology, cardiovascular, and general medicine worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback